retatrutide phase 2 trial weight loss VisualAbstract: reduces body by 17.5% in patients with obesity Retatrutide for Weight Loss: 2026

These medicines mimic the action of GLP-1, a naturally occurring hormone produced in the intestine in response to food intake

The National Heart, Lung, and Blood Institute provides evidence-based sleep recommendations that apply directly to athletic recovery

Willpower is trying to override biological systems designed to keep you alive

It is not approved or intended for human or animal use, and any discussion of biological activity refers only to preclinical or in vitro research

GLP-1 is a physiological hormone that has multiple actions on glucose, mediated by the GLP-1 receptors

Week 1-4: Begin with a low dose, often administered once weekly via injection